HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Zaki, M. H. Articles by Sterman, M. Search for Related Content PubMed PubMed Citation Articles by Zaki, M. H. Articles by Sterman, M.

Further Trials with Astiban® in Schistosomiasis Mansoni: The Effect of Increased Dosage^*

Mahfouz H. Zaki, Stanley de Ramos, Howard B. Shookhoff AND Max Sterman^||

A random sample of 19 Puerto Rican patients infected with Schistosoma mansoni were treated with a 40- to 80-mg dose of Astiban®/kg of body weight over periods ranging from 11 to 16 days. In spite of the high cure rate of 94%, the frequency and severity of the side effects do not justify the use of this massive dose in schistosomiasis chemotherapy.

^* Presented at the Thirteenth Annual Meeting of the American Society of Tropical Medicine and Hygiene, New York City, November, 1964.

Assistant Professor of Environmental Medicine and Community Health, Downstate Medical Center, State University of New York. Present address: 450 Clarkson Ave., Brooklyn, New York 11203.

Physician in Charge, Morrisania Tropical Disease Clinic, New York City Health Department.

Chief, Tropical Disease Division, New York City Health Department.

^|| Physician in Charge, Washington Heights Tropical Disease Clinic, New York City Health Department.